[关键词]
[摘要]
葡萄膜炎(uveitis)是临床常见的累及虹膜、睫状体、玻璃体、脉络膜、视网膜及视网膜血管的一组炎症疾病，原因复杂，由于葡萄膜炎的发病机制并未阐明清楚，寻找有效治疗葡萄膜炎的药物一直是眼科研究的主要方向，除了传统的糖皮质激素、睫状肌麻痹剂、非甾体类抗炎药、免疫抑制剂对葡萄膜炎有着不错的疗效，随着分子生物学的发展，新型生物制剂、基因治疗、中医药在治疗葡萄膜炎上也占有一席之地。本文旨在对葡萄膜炎最新的治疗进展进行综述。
[Key word]
[Abstract]
The uveitis is a clinical common involving the iris, ciliary body, vitreous body, choroid, retina and retinal blood vessels, a group of inflammatory disease causes complex, due to the pathogenesis of uveitis did not clarify clearly, looking for effective treatment of uveitis drugs has been the main direction of ophthalmic research, in addition to the traditional glucocorticoid, cycloplegia agent, nonsteroidal anti-inflammatory drugs(nsaids), immune inhibitor has a good curative effect on uveitis, along with the development of molecular biology, a new type of biological agents, gene therapy, could fairly claim a place in the history of Chinese medicine in the treatment of uveitis. This article aims to review the latest progress in the treatment of uveitis.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No.81770948); 福建省科技创新领军人才基金资助项目(No.2016B011)
